Exemestane As Treatment In Neoadjuvant Setting For Operable Breast Cancer Patients
To evaluate clinical and pathologic response rates following primary hormonal therapy by exemestane (Aromasin速)
Breast Neoplasms
DRUG: exemestane (Aromasin速)
To evaluate clinical and pathologic response rates following primary hormonal therapy by exemestane (Aromasin速)
To evaluate breast conservative surgery rate; To evaluate intratumoral anti-aromatase activity.
To evaluate clinical and pathologic response rates following primary hormonal therapy by exemestane (Aromasin速)